BATF3 and metabolic syndrome: To investigate the role of intestinal bacteria in the development of metabolic syndrome in Batf3-/-, we treated WT and Batf3-/- mice with broad-spectrum antibiotics (Abx) from the time of weaning until 16 weeks of age (Figure S6A).